Metformin improves high-fat diet-induced insulin resistance in mice by downregulating the expression of long noncoding RNA NONMMUT031874.2

Metformin (MET) is the first-line therapeutic option for patients with type 2 diabetes that has garnered substantial attention over recent years. However, an insufficient number of studies have been performed to assess its effects on insulin resistance and the expression profile of long noncoding RN...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhi-Mei, Liu, Zhi-Hong, Nie, Qian, Zhang, Xue-Mei, Yang, Li-Qun, Wang, Chao, Yang, Lin-Lin, Song, Guang-Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987942/
https://www.ncbi.nlm.nih.gov/pubmed/35401798
http://dx.doi.org/10.3892/etm.2022.11261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987942/
https://www.ncbi.nlm.nih.gov/pubmed/35401798
http://dx.doi.org/10.3892/etm.2022.11261

Ejemplares similares